|
BIBLIOGRAPHIC DATA |
(11) Patent Number | 035519 |
Date of Registration in the Register of Eurasian Patents | 2020.06.26 |
(21) Application Number | 201891239 |
(22) Filling Date | 2016.11.30 |
(51) IPC |
C07D 417/14 (2006.01)
A61K 31/433 (2006.01)
A61P 35/00 (2006.01) |
(43)(13) Application Publication Date(s), Kind Code(s) | A1 2018.11.30 Issue No 11  title, specification
|
(45)(13) Patent Publication Date(s), Kind Code(s) | B1 2020.06.29 Issue No 06 title, specification
B9 2020.08.10 Issue No 08 title, specification
|
(31) Number(s) assigned to Priority Application(s) | 62/260784
|
(32) Date(s) of filing of Priority Application(s) | 2015.11.30
|
(33) Priority Application Office | US
|
(86) PCT Application Number | EP2016/079253 |
(87) PCT Publication Number | 2017/093301 2017.06.08 |
(71) Applicant(s) | АСТРАЗЕНЕКА АБ (SE); КЭНСЕР РИСЕРЧ ТЕКНОЛОДЖИ ЛИМИТЕД (GB) |
(72) Inventor(s) | Финлей Морис Реймонд Верскойл, Перкинс Дэвид Роберт, Ниссинк Йоханнес Вилхелмус Мария, Раубо Петр Энтони, Смит Питер Дункан, Бэйли Эндрю (GB) |
(73) Patent Owner(s) | АСТРАЗЕНЕКА АБ (SE); КЭНСЕР РИСЕРЧ ТЕКНОЛОДЖИ ЛИМИТЕД (GB) |
(54) Title | 1,3,4-ТИАДИАЗОЛЬНЫЕ СОЕДИНЕНИЯ И ИХ ПРИМЕНЕНИЕ В ЛЕЧЕНИИ РАКА |
|
|
REPRESENTATIVES |
Patent Owner's Representative(s) | ПОЛИКАРПОВ Александр Викторович (RU),СОКОЛОВА Марина Владимировна (RU),ПУТИНЦЕВ Алексей Игоревич (RU),ЧЕРКАС Дмитрий Александрович (RU),ИГНАТЬЕВ Алексей Владимирович (RU),БИЛЫК Александр Владимирович (RU) |
Correspondence Address | ЗАО "НЕВИНПАТ"пер. Пирогова, д. 7, г. Санкт-Петербург, Россия, 190000 |
|
|
INFORMATION ON LEGAL STATUS CHANGES |
MM4A
Lapse of a Eurasian patent in a Contracting State due to non-payment within the time limit of renewal fees | Issue: 2021-07
Date: 2021.07.09 | Code of state, where the patent has lapsed:
AM, AZ, BY, KG, KZ, TJ, TM
Lapse date: 2020.12.01.
|
TH4A
Reprint of the description of invention in a Eurasian patent (list of corrections applied, B9 publication) | Issue: 2020-08
Date: 2020.08.10 | Следует читать: (57) 1. ...
(2S)-2-[3-(дифторметокси)фенил]-2-(диметиламино)-N-[5-[[(3R)-1-пиридазин-3-илпирролидин-3-ил]амино]-1,3,4-тиадиазол-2-ил]ацетамида; ...
|
|
| VALIDITY IN CONTRACTING STATES AND THE REPUBLIC OF MOLDOVA |
| First annual fee payment due date | 2020.11.30 | | Validity of the patent in the territory of Contracting States and the Republic of Moldova |
| Year | Period |
AM | AZ | BY | KG | KZ | RU | TJ | TM |
| 1 | 2016.11.30 - 2017.11.30 | √ | √ | √ | √ | √ | √ | √ | √ | | 2 | 2017.12.01 - 2018.11.30 | √ | √ | √ | √ | √ | √ | √ | √ | | 3 | 2018.12.01 - 2019.11.30 | √ | √ | √ | √ | √ | √ | √ | √ | | 4 | 2019.12.01 - 2020.11.30 | √ | √ | √ | √ | √ | √ | √ | √ | | 5 | 2020.12.01 - 2021.11.30 | - | - | - | - | - | √ | - | - | | 6 | 2021.12.01 - 2022.11.30 | - | - | - | - | - | √ | - | - | | 7 | 2022.12.01 - 2023.11.30 | - | - | - | - | - | √ | - | - | | 8 | 2023.12.01 - 2024.11.30 | - | - | - | - | - | √ | - | - |
|
|
|
